Gabapentin

Product NDC: 69097-811
11-digit product format: 690970811
Labeler code: 69097
Product ID: 69097-811_69887d93-de9a-4397-a629-a0ce8e62c69a
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Gabapentin
Dosage form: TABLET
Route: ORAL
Labeler: Cipla USA Inc.
Application: ANDA202764
Marketing category: ANDA
Marketing start: 2016-07-22
Substance: GABAPENTIN
Active strength: 800 mg/1
Pharmacologic classes: Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A202764-001	GABAPENTIN	GABAPENTIN	600MG	TABLET / ORAL			2012-10-16
A202764-002	GABAPENTIN	GABAPENTIN	800MG	TABLET / ORAL			2012-10-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 52 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202764-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202764-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202764-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A202764-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202764-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A202764-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202764-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A202764-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202764-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A202764-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202764-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A202764-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202764-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202764-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202764-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A202764-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202764-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A202764-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202764-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A202764-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202764-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A202764-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202764-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A202764-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202764-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A202764-002	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202764-001	AB1	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202764-002	AB1	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202764-001	AB1	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A202764-002	AB1	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202764-001	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A202764-002	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202764-001	AB	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202764-002	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202764-001	AB	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202764-002	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202764-001	AB	1	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202764-002	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202764-001	AB	1	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202764-002	AB	1	`3f0d92c62455…`

Additional Listing Data#

Finished product: Yes
Brand name base: Gabapentin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	800 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310433	Internal RxNorm lookup
310434	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7c3ac86f-b8f7-42bf-942a-db854d946e54	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
69097-811-02	Gabapentin	30 in 1 BOTTLE	TABLET	30	6
69097-811-07	Gabapentin	100 in 1 BOTTLE	TABLET	100	6
69097-811-12	Gabapentin	500 in 1 BOTTLE	TABLET	500	6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69097-811	GABAPENTIN TABLET [CIPLA USA INC.]	6	Current NDC, Legacy NDC, 3 package rows	20230121_7c3ac86f-b8f7-42bf-942a-db854d946e54.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GABAPENTIN	GABAPENTIN	Exelan Pharmaceuticals Inc.	323dad14-ded9-4432-a265-c957e46cc6db	2023-03-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202764 application number: ANDA202764
Gabapentin	GABAPENTIN	Cipla USA Inc.	7c3ac86f-b8f7-42bf-942a-db854d946e54	2023-01-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202764 application number: ANDA202764 ndc (product): 69097-811
Gabapentin	GABAPENTIN	Proficient Rx LP	f6baeb5c-ca9c-4730-aeb8-8f8732e8ca3a	2021-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202764 application number: ANDA202764

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310433	gabapentin 600 MG Oral Tablet	PSN	7c3ac86f-b8f7-42bf-942a-db854d946e54	6
310434	gabapentin 800 MG Oral Tablet	PSN	7c3ac86f-b8f7-42bf-942a-db854d946e54	6
310433	gabapentin 600 MG Oral Tablet	SCD	7c3ac86f-b8f7-42bf-942a-db854d946e54	6
310434	gabapentin 800 MG Oral Tablet	SCD	7c3ac86f-b8f7-42bf-942a-db854d946e54	6
310433	gabapentin 600 MG Oral Tablet	PSN	5a05a77b-ab0d-d3f8-e053-2a91aa0a906f	1
310434	gabapentin 800 MG Oral Tablet	PSN	5a05a77b-ab0d-d3f8-e053-2a91aa0a906f	1
310434	gabapentin 800 MG Oral Tablet	PSN	90e82e0f-1a0a-4667-94ed-7bd9ed6472ba	1
310433	gabapentin 600 MG Oral Tablet	SCD	5a05a77b-ab0d-d3f8-e053-2a91aa0a906f	1
310434	gabapentin 800 MG Oral Tablet	SCD	5a05a77b-ab0d-d3f8-e053-2a91aa0a906f	1
310434	gabapentin 800 MG Oral Tablet	SCD	90e82e0f-1a0a-4667-94ed-7bd9ed6472ba	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
69097-811-02	69097081102	30 TABLET in 1 BOTTLE (69097-811-02)	30 tablet	2016-07-22	0000-00-00	No	No	Current
69097-811-07	69097081107	100 TABLET in 1 BOTTLE (69097-811-07)	100 tablet	2016-07-22	0000-00-00	No	No	Current
69097-811-12	69097081112	500 TABLET in 1 BOTTLE (69097-811-12)	500 tablet	2016-07-22	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Gabapentin	Cipla USA Inc. \| InvaGen Pharmaceuticals Inc \| Ascent Pharmaceuticals Inc	2023-01-20	HUMAN PRESCRIPTION DRUG LABEL	6
Gabapentin	Contract Pharmacy Services-PA \| Coupler Enterprises Inc.	2017-09-25	HUMAN PRESCRIPTION DRUG LABEL	1
Gabapentin	Aidarex Pharmaceuticals LLC	2016-11-21	HUMAN PRESCRIPTION DRUG LABEL	1